Journal
Frontiers in Cellular and Infection Microbiology
Publication Date
1-1-2025
Volume
15
First Page
1555171
Document Type
Open Access Publication
DOI
10.3389/fcimb.2025.1555171
Rights and Permissions
Lee G, Rosa BA, Fernandez-Baca MV, Martin J, Ore RA, Ortiz P, Cabada MM and Mitreva M (2025) Distinct gut microbiome features characterize Fasciola hepatica infection and predict triclabendazole treatment outcomes in Peruvian patients. Front. Cell. Infect. Microbiol. 15:1555171. doi: 10.3389/fcimb.2025.1555171 © 2025 Lee, Rosa, Fernandez-Baca, Martin, Ore, Ortiz, Cabada and Mitreva. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Lee, Giljae; Rosa, Bruce A; Fernandez-Baca, Martha V; Martin, John; Ore, Rodrigo A; Ortiz, Pedro; Cabada, Miguel M; and Mitreva, Makedonka, "Distinct gut microbiome features characterize Fasciola hepatica infection and predict triclabendazole treatment outcomes in Peruvian patients." Frontiers in Cellular and Infection Microbiology. 15, 1555171 (2025).
https://digitalcommons.wustl.edu/oa_4/7600
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
